FGF4 and metastatic neoplasm: The number of metastatic nodes in the mediastinal lymph nodes of the lungs was significantly enhanced in AAV-SHH- or AAV-FGF4-treated mice (Fig. 8D), and the infiltrating area of metastatic tumors in the liver tissue was significantly increased (Fig. 8E).